CJC-1295 Side Effects: A Research Guide
CJC-1295 is a growth hormone releasing hormone (GHRH) analog studied for its effect on natural growth hormone output. This overview covers the side effects reported in research and community use. It is research information only.
Why side effects happen
Because CJC-1295 works by increasing growth hormone release, most reported effects trace back to that mechanism rather than direct toxicity. When growth hormone and the downstream hormone IGF-1 rise, the body can show predictable responses.
Commonly reported effects
- Water retention: mild puffiness, one of the most frequently mentioned effects.
- Tingling or numbness: in the hands, sometimes described as a carpal tunnel type feeling.
- Injection site reactions: redness, itching, or a small lump.
- Head rush or flushing: shortly after a dose, linked to vasodilation.
- Fatigue or vivid dreams: tied to changes in growth hormone rhythm.
Dose dependence
Effects such as water retention and tingling are more often reported at higher doses. Following the ranges on the CJC-1295 protocol page and measuring accurately helps keep exposure steady. Sourcing tested material from the supplier list removes contaminant driven effects.
What is not established
Long term human safety and effects on those with hormone sensitive conditions are unknown. Sustained elevation of growth hormone and IGF-1 is a theoretical concern that has not been fully characterized in people, which reinforces the research only status.